Skip to main content
. 2012 Sep 27;345:e6231. doi: 10.1136/bmj.e6231

Table 4.

 Risk of dementia associated with benzodiazepine use in nested case control study of 1633 elderly people form PAQUID study. Values are numbers (percentages) unless stated otherwise

Cases Controls Odds ratio (95%CI) by drug use
Ever use analysis
Univariate analysis*: (n=467) (n=1810)
 Benzodiazepine non-users 175 (37) 845 (46.7) 1.00
 Benzodiazepine ever users 233 (50) 741 (40.9) 1.54 (1.24 to 1.93)
 Missing exposure 59 (13) 224 (12.4) 1.30 (0.93 to 1.81)
Multivariable analysis*†: (n=449) (n=1771)
 Benzodiazepine non-users 174 (39) 844 (47.7) 1.00
 Benzodiazepine ever users 233 (52) 738 (41.7) 1.55 (1.24 to 1.95)
 Missing exposure 42 (9) 189 (10.7) 1.04 (0.71 to 1.53)
Recent/past use analysis
Univariate analysis*: (n=467) (n=1810)
 Benzodiazepine non-users 175 (37) 845 (46.7) 1.00
 Benzodiazepine recent users 17 (4) 52 (2.9) 1.58 (0.90 to 2.78)
 Benzodiazepine past users 216 (46) 689 (38.1) 1.54 (1.23 to 1.93)
 Missing exposure 59 (13) 224 (12.4) 1.30 (0.93 to 1.81)
Multivariable analysis*†: (n=449) (n=1771)
 Benzodiazepine non-users 174 (39) 844 (47.7) 1.00
 Benzodiazepine recent users 17 (4) 52 (2.9) 1.48 (0.83 to 2.63)
 Benzodiazepine past users 216 (48) 686 (38.7) 1.56 (1.23 to 1.98)
 Missing exposure 42 (9) 189 (10.7) 1.04 (0.71 to 1.53)

*Matched for age and sex.

†Adjusted for schooling duration, singleness, wine consumption, use of antihypertensive drugs, use of antidiabetic agents, use of statins, use of platelet inhibitors or oral anticoagulants, and significant depressive symptoms according to Center for Epidemiologic Studies depression scale (score ≥17 for men; ≥23 for women), 7 or 8 years before index date.